Jennifer Loske

Jennifer Loske

Auto-generated profile, based on publicly available information

Jennifer Loske

Molecular Epidemiology Unit, Berlin Institute of Health at the Charité - Universitätsmedizin Berlin, Berlin, Germany

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2020 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
RCRobert Lorenz Chua
Robert Lorenz Chua
SLSören Lukassen
Sören Lukassen
STSaskia Trump
Saskia Trump
BHBianca P. Hennig
Bianca P. Hennig
DWDaniel Wendisch
Daniel Wendisch
RERoland Eils
Roland Eils
To investigate the immune response and mechanisms associated with severe coronavirus disease 2019 (COVID-19), we performed single-cell RNA sequencing on nasopharyngeal and bronchial samples from 19 clinically well-characterized patients with moderate or critical disease and from five healthy controls. We identified airway epithelial cell types and states vulnerable to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In patients with COVID-19, epithelial cells showed an average three-fold increase in expression of the SARS-CoV-2 entry receptor ACE2, which correlated with interferon signals by immune cells. Compared to moderate cases, critical cases exhibited stronger interactions between epithelial and immune cells, as indicated by ligand–receptor expression profiles, and activated immune cells, including inflammatory macrophages expressing CCL2, CCL3, CCL20, CXCL1, CXCL3, CXCL10, IL8, IL1B and TNF. The transcriptional differences in critical cases compared to moderate cases likely contribute to clinical observations of heightened inflammatory tissue damage, lung injury and respiratory failure. Our data suggest that pharmacologic inhibition of the CCR1 and/or CCR5 pathways might suppress immune hyperactivation in critical COVID-19.

18 August 2021 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
JLJ. Loske
J. Loske
JRJ. Röhmel
J. Röhmel
SLSören Lukassen
Sören Lukassen
SSS. Stricker
S. Stricker
VMV. G. Magalhães
V. G. Magalhães
ILI. Lehmann
I. Lehmann

24 December 2020 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
STSaskia Trump
Saskia Trump
SLSören Lukassen
Sören Lukassen
MAMarkus S. Anker
Markus S. Anker
RCRobert Lorenz Chua
Robert Lorenz Chua
JLJohannes Liebig
Johannes Liebig
ILIrina Lehmann
Irina Lehmann

11 July 2020 in Liver International
Verified
Journal Article
Open access
PDF file
CXChenchen Xu
Chenchen Xu
MMMariya Markova
Mariya Markova
NSNicole Seebeck
Nicole Seebeck
ALAnne Loft
Anne Loft
SHSilke Hornemann
Silke Hornemann
APAndreas F.H. Pfeiffer
Andreas F.H. Pfeiffer
Background and aims: Non‐alcoholic fatty liver disease (NAFLD) is becoming increasingly prevalent and nutrition intervention remains the most important therapeutic approach for NAFLD. Our aim was to investigate whether low‐ (LP) or high‐protein (HP) diets are more effective in reducing liver fat and reversing NAFLD and which mechanisms are involved.Methods: 19 participants with morbid obesity undergoing bariatric surgery were randomized into two hypocaloric (1500‐1600 kcal/day) diet groups, a low protein (10E% protein) and a high protein (30E% protein), for three weeks prior to surgery. Intrahepatic lipid levels (IHL) and serum fibroblast growth factor 21 (FGF21) were measured before and after the dietary intervention. Autophagy flux, histology, mitochondrial activity and gene expression analyses were performed in liver samples collected during surgery.Results: IHL levels decreased by 42.6% in the HP group, but were not significantly changed in the LP group despite similar weight loss. Hepatic autophagy flux and serum FGF21 increased by 66.7% and 42.2%, respectively, after 3 weeks in the LP group only. Expression levels of fat uptake and lipid biosynthesis genes were lower in the HP group compared with those in the LP group. RNA‐seq analysis revealed lower activity of inflammatory pathways upon HP diet. Hepatic mitochondrial activity and expression of β‐oxidation genes did not increase in the HP group.Conclusions: HP diet more effectively reduces hepatic fat than LP diet despite of lower autophagy and FGF21. Our data suggest that liver fat reduction upon HP diets result primarily from suppression of fat uptake and lipid biosynthesis.

1 June 2024 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
JLJennifer Loske
Jennifer Loske
MVMirjam Völler
Mirjam Völler
SLSören Lukassen
Sören Lukassen
MSMirjam Stahl
Mirjam Stahl
LTLoreen Thürmann
Loreen Thürmann
STSaskia Trump
Saskia Trump
Rationale: Pharmacological improvement of cystic fibrosis transmembrane conductance regulator (CFTR) function with elexacaftor/tezacaftor/ivacaftor (ETI) provides unprecedented improvements in lung function and other clinical outcomes in patients with cystic fibrosis (CF). However, ETI effects on impaired mucosal homeostasis and host defense at the molecular and cellular levels in the airways of patients with CF remain unknown. Objectives: To investigate effects of ETI on the transcriptome of nasal epithelial and immune cells from children with CF at the single-cell level. Methods: Nasal swabs from 13 children with CF and at least one F508del allele aged 6 to 11 years were collected at baseline and 3 months after initiation of ETI, subjected to single-cell RNA sequencing, and compared with swabs from 12 age-matched healthy children. Measurements and Main Results: Proportions of CFTR-positive cells were decreased in epithelial basal, club, and goblet cells, but not in ionocytes, from children with CF at baseline and were restored by ETI therapy to nearly healthy levels. Single-cell transcriptomics revealed an impaired IFN signaling and reduced expression of major histocompatibility complex classes I and II encoding genes in epithelial cells of children with CF at baseline, which was partially restored by ETI. In addition, ETI therapy markedly reduced the inflammatory phenotype of immune cells, particularly of neutrophils and macrophages. Conclusions: Pharmacological improvement of CFTR function improves innate mucosal immunity and reduces immune cell inflammatory responses in the upper airways of children with CF at the single-cell level, highlighting the potential to restore epithelial homeostasis and host defense in CF airways by early initiation of ETI therapy.

28 June 2021 in medRxiv
Verified
Preprint
Open access
PDF file
JLJ Loske
J Loske
JRJ Röhmel
J Röhmel
SLSören Lukassen
Sören Lukassen
SSS Stricker
S Stricker
VMVg Magalhães
Vg Magalhães
ILI Lehmann
I Lehmann
Children are consistently reported to have reduced SARS-CoV-2 infection rates and a substantially lower risk for developing severe COVID-19. However, the molecular mechanisms underlying protection against COVID-19 in younger age groups remain widely unknown. Here, we systematically characterized the single-cell transcriptional landscape in the upper airways in SARS-CoV-2 negative and age-matched SARS-CoV-2 positive children (n=42) and corresponding samples from adults (n=44), covering an age range of four weeks to 77 years. Children displayed higher basal expression of the relevant pattern recognition receptor (PRR) pathways in upper airway epithelial cells, macrophages, and dendritic cells, resulting in stronger innate antiviral responses upon SARS-CoV-2 infection compared to adults. We further detected distinct immune cell subpopulations with an overall dominance of neutrophils and a population of cytotoxic T cells occurring predominantly in children. Our study provides evidence that the airway epithelial and mucosal immune cells of children are pre-activated and primed for virus sensing, resulting in a stronger early innate antiviral responses to SARS-CoV-2 infection compared to adults.